Pfizer Inc
NYSE: PFE
$27.46
+$0.10 (+0.4%)
Closing Price on November 7, 2024
PFE Articles
Merrill Lynch has many stocks to buy and these are some of its top defensive stocks and dividend stocks that may help insulate investors during pullbacks or times of weakness.
Published:
Last Updated:
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger...
Published:
Last Updated:
Five of the 30 Dow Jones industrials are down so far in 2019, and some more are literally just one bad day away from being down for the year.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
As of the most recently reported period, short sellers favored Pfizer, Intel and Apple above all other Dow stocks.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
As of the most recently reported period, short sellers favored Pfizer, Intel and Apple above all other Dow stocks.
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch Income Portfolio portfolio looking for high-yielding Buy-rated companies and found the following five from different sectors that are solid plays now.
Published:
Last Updated:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
As of the most recently reported period, short sellers favored Apple, Intel and Pfizer above all other Dow stocks.
Published:
Last Updated:
It's an impressive day when two IPOs are well received when drug-selling revenues are unlikely for quite some time, and even longer before profits can be considered.
Published:
Last Updated:
Drugmaker Pfizer beat estimates on both the top and bottom lines for the first quarter, and shares rallied after the report.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly results this week.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
As of the most recently reported period, short sellers favored Pfizer, Apple and Intel above all other Dow stocks.
Published:
Last Updated: